Cooper Companies, Inc. (The) (NYSE:COO) had its price target raised by Stifel Nicolaus from $265.00 to $275.00 in a research note released on Tuesday, Marketbeat reports. They currently have a buy rating on the medical device company’s stock.

Several other analysts also recently issued reports on the stock. BMO Capital Markets reissued an outperform rating and issued a $255.00 price objective (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research note on Monday, June 5th. Jefferies Group LLC reissued a buy rating and issued a $250.00 price objective (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research note on Saturday, June 3rd. Zacks Investment Research downgraded shares of Cooper Companies, Inc. (The) from a buy rating to a hold rating in a research note on Thursday, June 22nd. KeyCorp reissued a hold rating on shares of Cooper Companies, Inc. (The) in a research note on Monday, August 28th. Finally, Piper Jaffray Companies raised their price objective on shares of Cooper Companies, Inc. (The) from $265.00 to $280.00 and gave the stock an overweight rating in a research note on Friday, September 1st. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Cooper Companies, Inc. (The) has an average rating of Buy and an average target price of $257.60.

Cooper Companies, Inc. (NYSE:COO) opened at 245.21 on Tuesday. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39. The company’s 50-day moving average price is $245.23 and its 200-day moving average price is $224.59. The stock has a market cap of $11.98 billion, a P/E ratio of 36.76 and a beta of 0.59.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.58 by $0.06. The business had revenue of $556.00 million during the quarter, compared to the consensus estimate of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the firm earned $2.30 earnings per share. Analysts forecast that Cooper Companies, Inc. will post $9.72 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/16/stifel-nicolaus-raises-cooper-companies-inc-the-coo-price-target-to-275-00.html.

In related news, CEO Paul L. Remmell sold 9,294 shares of Cooper Companies, Inc. (The) stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the transaction, the chief executive officer now directly owns 6,186 shares of the company’s stock, valued at $1,536,973.56. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Daniel G. Mcbride sold 6,000 shares of Cooper Companies, Inc. (The) stock in a transaction that occurred on Wednesday, June 21st. The shares were sold at an average price of $244.23, for a total transaction of $1,465,380.00. Following the transaction, the chief operating officer now directly owns 34,395 shares in the company, valued at $8,400,290.85. The disclosure for this sale can be found here. Over the last three months, insiders have sold 20,992 shares of company stock worth $5,167,628. 1.60% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Lord Abbett & CO. LLC boosted its stake in Cooper Companies, Inc. (The) by 2.1% in the second quarter. Lord Abbett & CO. LLC now owns 405,831 shares of the medical device company’s stock valued at $97,164,000 after acquiring an additional 8,316 shares in the last quarter. Sentry Investment Management LLC boosted its stake in Cooper Companies, Inc. (The) by 0.7% in the second quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock valued at $671,000 after acquiring an additional 19 shares in the last quarter. Toronto Dominion Bank boosted its stake in Cooper Companies, Inc. (The) by 25.3% in the second quarter. Toronto Dominion Bank now owns 16,552 shares of the medical device company’s stock valued at $3,963,000 after acquiring an additional 3,344 shares in the last quarter. Advisory Services Network LLC boosted its stake in Cooper Companies, Inc. (The) by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after acquiring an additional 107 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Cooper Companies, Inc. (The) in the second quarter valued at approximately $423,000. Institutional investors own 95.92% of the company’s stock.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.